| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 47,421 | 18,144 | | Cost of Revenue | 43,844 | 16,030 | | | Gross Profit | 3,577 | 2,114 | | | Operating Expenses | | Research Development | 559 | 199 | | Selling General and Administrative | 11,599 | 9,236 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (8,581) | (7,321) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 125 | 294 | | Earnings Before Interest And Taxes | (8,456) | (7,027) | | Interest Expense | 115 | 106 | | Income Before Tax | (8,571) | (7,133) | | Income Tax Expense | 167 | 61 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (8,738) | (7,194) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (8,738) | (7,194) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($8,738) | ($7,194) |
|
0.47% Nasdaq 
Income Statement
